CARDIONOVUM GmbH
Paolo Silvestri has extensive experience in the medical devices industry, with a strong background in clinical research and program management. Their career includes roles such as Clinical Research Director, Clinical Director, and Clinical Department Manager at reputable companies like CARDIONOVUM GmbH and St. Jude Medical. With a solid education in electronic engineering and biomedical engineering from Politecnico di Milano, Paolo also has experience in technical support for cardiologic implantable devices and validation management for dialysis equipment. Their expertise lies in coordinating clinical studies, data analysis, and report writing in the medical devices sector.
This person is not in any offices
CARDIONOVUM GmbH
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The company’s pioneering range of DCBs is based on the SAFEPAX® paclitaxel coating matrix which has the lowest wash-off rates on the market. The company’s strong commitment to clinical research ensures a continually deepening and expanding evidence-base in support of the clinical benefits of our products. Pioneers in medical devices. The worldwide first CE-approved DCB. With the first DCB market introduction, CARDIONOVUM contributed significantly to the establishment of a new medical device therapy to treat coronary and peripheral artery disease effectively. CARDIONOVUM consists of R & D staff, with the longest and most profound experience, in developing clinically advanced DCB and DES cardiovascular devices. “Live Deserves the Best”